Q1 2011

Filed Jan 13, 2011 · 10-Q · 44 days after period end · 0001144204-11-002095

Q1 2011 · 10-Q

Revenue—

Net Income

-$602.78K

no prior Q1 2010 on file

EPS Diluted

$0.01

no prior Q1 2010 on file

Operating Income-$601,617—

Operating Cash Flow-$498,355—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Nov 30, 2010 · filed Jan 13, 2011 · 44 d after period end

Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR